Table 1 Patient characteristics at the time of inclusion
From: How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
Characteristics | |
|---|---|
Number of patients | 30 |
Age (years) mean ± SD | 60 ± 16 |
SAPS 2 score median (IQR) | 46 (38–53.5) |
SOFA score median (IQR) | 8 (7–10) |
Etiology of ARDS no./total no. (%) | Community acquired pneumonia 11/30 (37) |
Ventilator associated pneumonia 10/30 (33) | |
Aspiration pneumonia 6/30 (20) | |
Extra pulmonary ARDS 3/30 (10) | |
Topography of ARDS no./total no. (%) | Lobar ARDS 13/30 (43) |
Diffuse ARDS 17/30 (57) | |
PaO2/FiO2 ratio median (IQR) | 102 (77–120) |
Vt (mL) ± SD | 385 ± 76 |
Vt mL/kg (PBW) | 6.1 ± 1.1 |
Pplat median (IQR) | 25 (22–27) |
PEEP median (IQR) | 10 (8–14) |
FiO2 median (IQR) | 75 (60–100) |
Other conditions no./total no. (%) | Septic shock 27/30 (90) |
Renal replacement therapy 1/30 (3) | |